Your browser doesn't support javascript.
loading
Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, ALK-Positive, TP53-Mutant NSCLC.
Urbán, László; Dóczi, Róbert; Vodicska, Barbara; Kormos, Dóra; Tóth, László; Takács, István; Várkondi, Edit; Tihanyi, Dóra; Lakatos, Dóra; Dirner, Anna; Vályi-Nagy, István; Peták, István.
Afiliación
  • Urbán L; Department of Pulmonology, Mátraháza University and Teaching Hospital, 3233 Mátraháza, Hungary.
  • Dóczi R; Oncompass Medicine Hungary Ltd., 1024 Budapest, Hungary.
  • Vodicska B; Oncompass Medicine Hungary Ltd., 1024 Budapest, Hungary.
  • Kormos D; Department of Internal Medicine and Lymphomatherapy V., BAZ County Central and Teaching Hospital, 3526 Miskolc, Hungary.
  • Tóth L; Department of Pulmonology, Mátraháza University and Teaching Hospital, 3233 Mátraháza, Hungary.
  • Takács I; Department of Internal Medicine and Lymphomatherapy V., BAZ County Central and Teaching Hospital, 3526 Miskolc, Hungary.
  • Várkondi E; Faculty of Healthcare, University of Miskolc, 3515 Miskolc, Hungary.
  • Tihanyi D; Oncompass Medicine Hungary Ltd., 1024 Budapest, Hungary.
  • Lakatos D; Oncompass Medicine Hungary Ltd., 1024 Budapest, Hungary.
  • Dirner A; Oncompass Medicine Hungary Ltd., 1024 Budapest, Hungary.
  • Vályi-Nagy I; Oncompass Medicine Hungary Ltd., 1024 Budapest, Hungary.
  • Peták I; National Hematology and Infectology Institute, Centrum Hospital of Southern Pest, 1097 Budapest, Hungary.
J Pers Med ; 10(3)2020 Aug 28.
Article en En | MEDLINE | ID: mdl-32872120
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: J Pers Med Año: 2020 Tipo del documento: Article País de afiliación: Hungria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: J Pers Med Año: 2020 Tipo del documento: Article País de afiliación: Hungria